Altimmune, Inc. - Laporan Laba Rugi (TTM)

Altimmune, Inc.
GB ˙ LSE ˙ US02155H2004
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Altimmune, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 6 8 7 6 3 4 4 3 3 -0 -0 -0 0 0 0 0 0 0 0 0
Change (%) 26.94 -16.80 -8.58 -44.65 27.99 -18.28 -3.58 -4.49 -102.05 16.18 2.53 -444.44 52.69 -3.76 -0.24 -87.29 -61.54 0.00 0.00
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 21 34 39 49 68 74 80 80 72 70 71 70 68 66 70 78 79 82 77 73
Change (%) 62.06 16.59 24.49 39.40 8.91 7.97 -0.18 -9.13 -2.58 0.52 -1.23 -2.68 -3.33 6.44 11.28 1.82 3.62 -6.88 -5.12
% of Revenue 320.66 409.40 573.68 781.24 1,967.71 1,674.40 2,212.18 2,290.13 2,178.91 -103,605.88 -89,641.77 -86,349.38 24,397.49 15,445.77 17,082.20 19,055.99 152,603.85 411,130.00 382,830.00 363,235.00
Gross Operating Profit -14 -25 -32 -42 -64 -69 -76 -76 -69 -71 -71 -70 -68 -65 -70 -78 -79 -82 -77 -73
Change (%) 77.98 27.39 31.47 51.74 7.89 9.64 -0.02 -9.34 2.20 0.53 -1.23 -3.19 -3.57 6.51 11.35 2.29 3.66 -6.89 -5.12
% of Revenue -220.66 -309.40 -473.68 -681.24 -1,867.71 -1,574.40 -2,112.18 -2,190.13 -2,078.91 103,705.88 89,741.77 86,449.38 -24,297.49 -15,345.77 -16,982.20 -18,955.99 -152,503.85 -411,030.00 -382,730.00 -363,135.00
SG&A 11 13 15 16 16 15 16 17 17 17 17 18 18 18 19 20 20 21 22 22
Change (%) 18.87 11.27 7.58 -0.41 -2.13 3.93 4.69 2.00 0.16 0.61 2.03 0.13 2.99 4.31 4.41 2.30 3.75 3.25 0.44
% of Revenue 172.33 161.39 215.83 253.98 457.03 349.50 444.48 482.59 515.40 -25,197.06 -21,820.25 -21,713.58 6,311.83 4,257.51 4,614.15 4,829.58 38,861.54 104,830.00 108,235.00 108,715.00
R&D
Change (%)
% of Revenue
OpEx 32 47 54 64 84 89 96 96 89 88 88 88 86 84 89 98 100 103 98 94
Change (%) 46.96 15.09 19.87 29.64 6.83 7.27 0.63 -7.19 -2.06 0.54 -0.60 -2.12 -2.03 5.98 9.82 1.91 3.65 -4.82 -3.89
% of Revenue 493.00 570.78 789.51 1,035.22 2,424.74 2,023.90 2,656.66 2,772.72 2,694.31 -128,802.94 -111,462.03 -108,062.96 30,709.32 19,703.29 21,696.34 23,885.57 191,465.38 515,960.00 491,065.00 471,950.00
Operating Income -25 -39 -47 -58 -80 -85 -92 -93 -86 -88 -88 -88 -85 -84 -89 -97 -100 -103 -98 -94
Change (%) 52.06 21.86 23.99 37.58 5.92 8.60 0.80 -7.29 1.80 0.55 -0.59 -2.52 -2.21 6.03 9.87 2.29 3.68 -4.83 -3.89
% of Revenue -393.00 -470.78 -689.51 -935.22 -2,324.74 -1,923.90 -2,556.66 -2,672.72 -2,594.31 128,902.94 111,562.03 108,162.96 -30,609.32 -19,603.29 -21,596.34 -23,785.57 -191,365.38 -515,860.00 -490,965.00 -471,850.00
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) 26.15 107.37 95.68 80.37 -92.75 1,000.00 78.18 31.63 -93.80 -2.86 -2.94 -69.70 -10.00 -0.00 2,922.22
% of Revenue -0.12 -0.12 -0.29 -0.61 -2.00 -0.11 -1.53 -2.82 -3.89 11.76 -8.22 -8.29 -8.07 -19.23 -45.00 -45.00 -1,360.00
Net Income -43 -49 -60 -68 -84 -97 -102 -97 -87 -85 -85 -81 -78 -88 -93 -101 -104 -95 -90 -88
Change (%) 15.35 22.38 13.43 23.12 15.83 4.70 -4.64 -10.31 -2.56 0.76 -4.74 -3.50 12.72 4.88 9.25 2.15 -8.17 -5.07 -2.76
% of Revenue -659.41 -599.20 -881.35 -1,093.58 -2,432.67 -2,201.59 -2,820.64 -2,789.53 -2,619.52 124,577.94 108,046.84 100,383.95 -28,124.01 -20,762.21 -22,626.10 -24,778.97 -199,076.92 -475,295.00 -451,200.00 -438,730.00

Source: Capital IQ

Other Listings
MX:ALT1
US:ALT US$ 3.78
DE:3G0 € 3.04
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista